Michelle Furtado

Truro, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study.

The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study.

Journal: The Lancet. Oncology

Published: July 18, 2024

Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.

Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.

Journal: British journal of haematology

Published: November 21, 2023

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: January 16, 2023

Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.

Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.

Journal: British journal of haematology

Published: December 21, 2022

Symptomatic Thyroglossal Duct Cyst Presenting With Synchronous and Localized Tongue Base Extranodal Mantle Cell Lymphoma. A Unique Case Report Demonstrating Lymphoma Colonization of Cyst Wall, Potentially Relating to a Persistent Embryological Foramen Cecum Remnant.

Symptomatic Thyroglossal Duct Cyst Presenting With Synchronous and Localized Tongue Base Extranodal Mantle Cell Lymphoma. A Unique Case Report Demonstrating Lymphoma Colonization of Cyst Wall, Potentially Relating to a Persistent Embryological Foramen Cecum Remnant.

Journal: International journal of surgical pathology

Published: April 08, 2022

An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignancies.

An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignancies.

Journal: EJHaem

Published: February 16, 2021

The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma.

The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma.

Journal: Leukemia & lymphoma

Published: May 22, 2015

Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.

Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.

Journal: British journal of haematology

Published: January 07, 2015

Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma.

Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma.

Journal: British journal of haematology

Published: April 03, 2014

Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial.

Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial.

Journal: British journal of haematology

Published: March 27, 2014

Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma.

Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma.

Journal: British journal of haematology

Published: July 26, 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin.

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin.

Journal: Clinical Medicine Insights. Oncology

Published: January 19, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026